Y-MABS THERAPEUTICS, ApS
CVR 34879524 · Private limited company (ApS) · Dissolved after merger
Y-MABS THERAPEUTICS, ApS is a Private limited company (ApS), founded on , based in København K. The company is registered in the industry fremstilling af farmaceutiske præparater. Y-MABS THERAPEUTICS, ApS went bankrupt on – 4.0 years after it was founded. 2 annual reports have been published. The latest annual report (31 Dec 2014) shows equity of DKK 72k and a net result of DKK -15k.
Bankruptcy
- Bankruptcy date
- Status
- Dissolved after merger
- First distress status
- Being compulsorily dissolved from
- Age at bankruptcy
- 4.0 years
Company details
- CVR number
- 34879524
- Status
- Dissolved after merger
- Company type
- Private limited company (ApS)
- Founded
- Ceased
- Address
- Ny Østergade 3
1101 København K - Municipality
- København
- Industry
- Fremstilling af farmaceutiske præparater (212000)
Bankruptcies in the industry: Fremstilling af farmaceutiske præparater - Share capital
- DKK 81k
- Auditor
- Grant Thornton, Statsautoriseret Revisionspartnerselskab
- Audit opted out
- No
Warning signs
| Annual reports filed late | 0 of 2 |
| Missing annual report | No |
| Negative equity | No |
| Equity ratio | 88.8% |
| Current ratio | 892% |
| Moves (last 2 years) | 2 |
| CEO changes in total | 0 |
| CEO's previous bankruptcies | 2 |
| Other companies at the address | 128 |
| Going-concern uncertainty | No |
Financials and key figures
| Financial year | 2014 | 2013 |
|---|---|---|
| Gross profit | DKK -15k | DKK -13k |
| Net profit | DKK -15k | DKK -88k |
| Equity | DKK 72k | DKK -8,000 |
| Total assets | DKK 81k | DKK 0 |
| Cash | DKK 81k | – |
| Short-term debt | DKK 9,128 | – |
Latest annual report: Reporting class B · auditor's statement: Revisionspåtegning · Grant Thornton, Statsautoriseret Revisionspartnerselskab.
Filed annual reports
| Reporting period | Published | Days after period end | |
|---|---|---|---|
| 1 Jan 2014 – 31 Dec 2014 | 12 | ||
| 5 Dec 2012 – 31 Dec 2013 | 170 |
The annual report must reach the Danish Business Authority no later than 5 months after the end of the financial year. We mark reports published more than 6 months after as “late”.
Management, owners and auditor
| Role | Name | From | To |
|---|---|---|---|
| CEO | Thomas Gad | ||
| Auditor | Grant Thornton, Godkendt Revisionspartnerselskab | ||
| Founder | Thomas Gad |
The CEOs' other companies
Thomas Gad – 5 other companies, of which 3 bankrupt
- G. Estates ApS Bankrupt 19 Jan 2022
- SINGAD HOLDING ApS Bankrupt 5 Mar 2014
- SINGAD PHARMA ApS Bankrupt 6 May 2013
- ECU INVEST ApS Compulsorily dissolved
- Y-mAbs Therapeutics A/S Active
Address history (3 moves)
| Ny Østergade 3, 1101 København K | |
| Ny Østergade 3, 1101 København K | |
| c/o Thomas Gad, Malmøgade 6, 2. tv, 2100 København Ø | |
| Vibe Alle 5, 2980 Kokkedal |
Former names
| Y-MABS THERAPEUTICS, ApS | – |
| EQ MEDICINE ApS | – |
Other companies at the same address
- AMS FINANS A/S Bankrupt
- BORCH EJENDOMSADMINISTRATION ApS Bankrupt
- C & L GROUP A/S Bankrupt
- CAFE KETCHUP I TIVOLI ApS Bankrupt
- COPENHAGEN LONDON BALTIC FORESTS ApS Bankrupt
- Cultimo ApS Bankrupt
- DANKO 1 INVEST ApS Bankrupt
- Dent-X ApS Bankrupt
- EJENDOMSAKTIESELSKABET RAVNSBÆKGAARD Bankrupt
- EJENDOMSSELSKABET KELLERISHEGN I/S Bankrupt
- ERIK BRESLING ApS Bankrupt
- GERMAN RETAIL C INVEST ApS Bankrupt
- JAGTVEJ 101 EJENDOMSSELSKAB ApS Bankrupt
- K/S ISP SKELLEFTEÅ Bankrupt
- K/S PARKEN TÅRN D Bankrupt
- K/S STOCKHOLM III - HALLUNDA Bankrupt
- K/S SWEDEN REAL ESTATE PORTFOLIO Bankrupt
- KOMPLEMENTARSELSKABET STOCKHOLM III - HALLUNDA ApS Bankrupt
- KOMPLEMENTARSELSKABET ISP STOCKHOLM ApS Bankrupt
- KOMPLEMENTARSELSKABET NISTEDVEJ 48, ODENSE ApS Bankrupt
- KOMPLEMENTARSELSKABET PARKEN TÅRN D ApS Bankrupt
- KOMPLEMENTARSELSKABET SWEDEN REAL ESTATE PORTFOLIO ApS Bankrupt
- NY ØST 3 A/S Bankrupt
- PANTEBREV I PILESTRÆDE 23 ApS Bankrupt
- TABASCO KØBENHAVN ApS Bankrupt
Similar companies in København
- H. LUNDBECK A/S Valby
- GUNNAR KJEMS ApS København K
- Tetrapharm Therapeutics ApS København S
- Tetrapharm Bioengineering ApS København S
- Luvalis Pharma ApS Vanløse
- NeuroVersis Therapeutics ApS København K
- QuantumCell ApS København K
- Vautia Therapeutics ApS København K
- Corxel Pharmaceuticals Denmark ApS København V
- Dispersome IP ApS København Ø
- Maddox Pharma Swiss ApS København S
- Gefjon Pharma ApS København N
Questions and answers about Y-MABS THERAPEUTICS, ApS
Has Y-MABS THERAPEUTICS, ApS gone bankrupt?
Yes. Y-MABS THERAPEUTICS, ApS went bankrupt on 28 November 2016.
Who is the auditor of Y-MABS THERAPEUTICS, ApS?
Y-MABS THERAPEUTICS, ApS most recently used Grant Thornton, Statsautoriseret Revisionspartnerselskab.
When was Y-MABS THERAPEUTICS, ApS founded?
Y-MABS THERAPEUTICS, ApS was founded on 5 December 2012.
What is the equity of Y-MABS THERAPEUTICS, ApS?
Equity was DKK 72k according to the annual report for the period ending 31 December 2014.
Source: the CVR register and annual reports published by the Danish Business Authority. The information is updated continuously.